PE Hub

Warburg Pincus to invest up to $300 mln into Vertice Pharma

NEW YORK, Nov. 17, 2015 /PRNewswire/ — Pharmaceutical industry veterans Don DeGolyer and Andrew Saik today announced that they have launched Vertice Pharma, LLC (“Vertice Pharma” or “the Company”) in ...
Nasdaq

Arvinas Appoints Andrew Saik as Chief Financial Officer and Treasurer

- Awards Mr. Saik an Inducement Grant in accordance with Nasdaq Listing Rule 5635(c)(4) - "I am delighted to join this dynamic team and contribute to the company's future successes,” said Mr. Saik.
Business Insider

Edge Therapeutics Reports Third Quarter 2017 Financial ResultsAppoints Pharmaceutical Industry Veteran Andrew Saik as Chief Financial Officer

BERKELEY HEIGHTS, N.J., Nov. 01, 2017 (GLOBE NEWSWIRE) -- Edge Therapeutics ®, Inc. (Nasdaq:EDGE), a clinical-stage biotechnology company developing novel hospital-based therapies for the management ...
Nasdaq

Menlo Therapeutics Appoints Andrew Saik as Chief Financial Officer

BRIDGEWATER, N.J., March 24, 2020 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (Nasdaq: MNLO) (“Menlo” or the “Company”), a biopharmaceutical company focused on developing and commercializing ...
FierceBiotech

Auxilium Pharmaceuticals (AUXL) Appoints Andrew Saik Chief Financial Officer

CHESTERBROOK, Pa., Aug. 11, 2014 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a fully integrated specialty biopharmaceutical company, announced that ...